ACXP Acurx Pharmaceuticals, Inc.: institutional ownership and insider trading
18 funds reported holding $243K of Acurx Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net sold $96.4K, with 1 new positions and 4 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
ACXP revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$2.25M, EPS -0.53
- Quarter ended Mar 31, 2026: revenue n/a, net income −$1.68M, EPS -0.62
- Quarter ended Dec 31, 2025: revenue n/a, net income −$1.58M, EPS -0.05
- Quarter ended Sep 30, 2025: revenue n/a, net income −$1.99M, EPS -1.23
Largest institutional holders of ACXP
- VANGUARD GROUP INC — $58.0K
- VANGUARD CAPITAL MANAGEMENT LLC — $48.2K
- GEODE CAPITAL MANAGEMENT, LLC — $40.9K
- VANGUARD FIDUCIARY TRUST CO — $25.1K
- JANE STREET GROUP, LLC — $24.4K
- Prospect Financial Services LLC — $21.4K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $11.6K
- Tower Research Capital LLC (TRC) — $4.25K
- WELLS FARGO & COMPANY/MN (WFC, WFCNP, WFC-PA, WFC-PC, WFC-PD, WFC-PL, WFC-PY, WFC-PZ) — $3.57K
- Westside Investment Management, Inc. — $2.56K
Recent ACXP insider trades
- Jan 6, 2025: Sailer Carl bought 24,631 shares ($25.1K)
- Jan 6, 2025: Luci David P bought 49,261 shares ($50.2K)
- Jan 6, 2025: Donohue James J. bought 9,852 shares ($10.0K)
- Jan 6, 2025: Deluccia Robert J bought 49,261 shares ($50.2K)
Who owns the most ACXP stock?
The largest institutional holders of Acurx Pharmaceuticals, Inc. in the latest 13F filings are VANGUARD GROUP INC ($58.0K), VANGUARD CAPITAL MANAGEMENT LLC ($48.2K), GEODE CAPITAL MANAGEMENT, LLC ($40.9K).
Are insiders buying or selling ACXP?
No open-market insider buys or sells of Acurx Pharmaceuticals, Inc. were reported in the last 12 months.